Raia Drogasil S.A. (OTCMKTS:RADLY) Stock Short Interest Report for October

Raia Drogasil S.A. (OTCMKTS:RADLY) was the target of a large decrease in short interest during the month of October. As of October 15th, there was short interest totaling 793 shares, a decrease of 40.3% from the September 30th total of 1,328 shares. Currently, 0.0% of the shares of the company are sold short. Based on an average trading volume of 349,085 shares, the short-interest ratio is currently 0.0 days.

Raia Drogasil Trading Up 3.3%

Shares of RADLY traded up $0.09 during mid-day trading on Monday, reaching $2.85. The stock had a trading volume of 1,177 shares, compared to its average volume of 83,700. Raia Drogasil has a 52-week low of $2.74 and a 52-week high of $5.34. The firm has a market cap of $3.75 billion and a price-to-earnings ratio of 19.00. The business’s fifty day moving average is $3.75 and its 200 day moving average is $4.08. The company has a debt-to-equity ratio of 0.99, a current ratio of 1.41 and a quick ratio of 0.58.

Raia Drogasil (OTCMKTS:RADLY) last announced its earnings results on Tuesday, August 4th. The company reported $0.05 earnings per share for the quarter, hitting the consensus estimate of $0.05. The company had revenue of $2.17 billion during the quarter, compared to analyst estimates of $2.32 billion. Raia Drogasil had a net margin of 2.99% and a return on equity of 20.12%. On average, sell-side analysts predict that Raia Drogasil will post 0.17 EPS for the current fiscal year.

Analysts Set New Price Targets

Separately, Jefferies Financial Group upgraded Raia Drogasil to a “buy” rating and set a $5.20 price objective on the stock in a research report on Sunday, October 18th. One investment analyst has rated the stock with a Buy rating and one has issued a Hold rating to the company’s stock. Based on data from MarketBeat, the stock presently has an average rating of “Moderate Buy” and an average price target of $5.20.

Raia Drogasil Company Profile

Raia Drogasil, now operating under the name RD Saúde, is a Brazilian healthcare and pharmacy retail company. It operates a network of pharmacies offering prescription medicines, over-the-counter drugs, vitamins, personal care products, beauty items and other health-related merchandise.

The company also provides digital purchasing and delivery services through its online channels, supporting customers with prescription fulfillment, health products and related services. Its operations include pharmacy-based healthcare initiatives designed to complement its retail business and improve access to everyday healthcare.

RD Saúde was created in 2011 through the merger of Drogasil and Droga Raia, two established Brazilian pharmacy chains.